TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases.

James S Wilmott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.